The $53bn (£41bn) plan, drawn up by Egypt and adopted by Arab leaders, would avoid displacing Palestinians from the enclave - but has been rejected by Israel and the US. President Donald Trump ...

Prince Muhammad Ali has left a comfortable life in Paris to fulfil an enduring dream -- return to Egypt, where his grandfather Farouk once ruled as king, hoping to restore the family's legacy. The ...

The GeoMap tool utilises Google Cloud’s scaleable infrastructure, BigQuery and Vertex AI, to integrate diverse datasets, enabling users to visualise and analyse geothermal potential across regions and ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Many companies are working to develop non-opioid-based pain therapies to address the opioid crisis. Vertex has also had success with its its non-opioid pain therapy VX-548 which met its primary ...

Other companies are also developing therapies using this approach. In March 2023, Tevard Biosciences entered a four-year global research collaboration with Vertex Pharmaceuticals to develop novel tRNA ...

Egypt’s economic outlook is on an upward trajectory, with a predicted GDP growth of 4.7% in 2025-2026, surpassing the IMF’s previous forecast of 4.1%. This growth is fueled by the country’s ...

Speaking in Washington DC, Opposition Leader Yair Lapid presented on Tuesday a “day after” plan for Gaza, envisioning an extended Egyptian guardianship of the war-torn Strip. “Israel cannot ...

Egypt’s $1 billion flagship antiquities museum was given an opening date after almost two decades of work, in what’s set to be a significant boost for the North African nation’s crucial ...

Egypt's Valley of the Kings is part of a massive necropolis along the Nile that includes the Mortuary Temple of Hatshepsut, Thutmose II's wife and half-sister. The king's tomb was discovered in ...

Sionna’s novel mechanism is distinctive from that of the CF market leader, Vertex Pharmaceuticals, with its therapeutic approach of CFTR modulation. With Vertex dominating the CF market with Trikafta ...